Protecting America from Seasonal and Pandemic Influenza Act of 2026

Key Points

• The bill sets a national goal to deliver the first doses of a finished flu vaccine within 12 weeks of a new pandemic strain emerging, with a plan due within 6 months of enactment. This aims to dramatically speed up the country's ability to respond to a flu pandemic.
• A second national goal calls for developing a universal flu vaccine within 10 years, which would protect against many flu strains at once and could end the need for a new shot every year. NIH and BARDA would publish a plan within one year.
• The bill directs HHS to create public-private partnerships to strengthen the domestic vaccine supply chain, covering everything from raw ingredients to finished vaccines to ancillary supplies like needles and syringes, reducing reliance on foreign suppliers.
• New programs would tackle vaccine hesitancy through targeted outreach, including a communications public-private partnership and a test-to-treat demonstration project at facilities serving vulnerable populations like nursing homes, tribal health clinics, and VA facilities.
• The bill authorizes billions in annual funding starting in fiscal year 2027, including $1 billion per year for the Strategic National Stockpile, $735 million for public health emergency preparedness, $681 million for the CDC immunization program, $335 million for pandemic influenza countermeasures, and $270 million for universal flu vaccine research.
• The bill creates a special "health defense operations" budget designation that would exempt certain public health preparedness spending from budget caps, and establishes a bypass budget process letting CDC, NIH, and ASPR submit their estimates directly to the president without HHS changes.

Votes

No votes have been recorded for this legislation yet.

Related Bills

No related bills have been identified yet.